Search research articles
Contact Us
Filters
Showing results (131-140 of 188) with videos related to
Page
of 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives
E Martinelli, D Ciardiello, G Martini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up
S De Placido, C Carlomagno, F Ciardiello, et al.
British Journal of Cancer
|
May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer
T Macarulla, A Cervantes, J Tabernero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides
N Normanno, C Bianco, V Damiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
D Arnold, B Lueza, J-Y Douillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
N Normanno, A M Rachiglio, M Lambiase, et al.
Ecancermedicalscience
|
January 26, 2012
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC)
G Aurilio, V Ricci, F De Vita, et al.
Oncology Reports
|
May 25, 2011
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
P Tagliaferri, P Correale, M Mottola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
F De Vita, F Giuliani, M Orditura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2009
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
J Tabernero, F Ciardiello, F Rivera, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 188) with videos related to
Sort By:
Page
of 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives
E Martinelli, D Ciardiello, G Martini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up
S De Placido, C Carlomagno, F Ciardiello, et al.
British Journal of Cancer
|
May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer
T Macarulla, A Cervantes, J Tabernero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides
N Normanno, C Bianco, V Damiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
D Arnold, B Lueza, J-Y Douillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
N Normanno, A M Rachiglio, M Lambiase, et al.
Ecancermedicalscience
|
January 26, 2012
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC)
G Aurilio, V Ricci, F De Vita, et al.
Oncology Reports
|
May 25, 2011
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
P Tagliaferri, P Correale, M Mottola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
F De Vita, F Giuliani, M Orditura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2009
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
J Tabernero, F Ciardiello, F Rivera, et al.
Page
of 19